8-K//Current report
Trillium Therapeutics Inc. 8-K
Accession 0001104659-21-127796
CIK 0001616212operating
Filed
Oct 19, 8:00 PM ET
Accepted
Oct 20, 6:03 AM ET
Size
225.0 KB
Accession
0001104659-21-127796
Documents
- 8-Ktm2130104d3_8k.htmPrimary
FORM 8-K
- EX-101.SCHtril-20211019.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABtril-20211019_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREtril-20211019_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLtm2130104d3_8k_htm.xml
IDEA: XBRL DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001104659-21-127796-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
Trillium Therapeutics Inc.
CIK 0001616212
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001616212
Filing Metadata
- Form type
- 8-K
- Filed
- Oct 19, 8:00 PM ET
- Accepted
- Oct 20, 6:03 AM ET
- Size
- 225.0 KB